PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Klinik für Innere Medizin II - Gastroenterologie, Hepatologie, Endokrinologie, Infektiologie, Universitätsklinikum Freiburg, Medizinische Fakultät, Albert-Ludwigs-Universität Freiburg.\', \'Klinik für Kardiologie I - Universitäts-Herzzentrum Freiburg-Bad Krozingen, Universitätsklinikum Freiburg, Medizinische Fakultät, Albert-Ludwigs-Universität Freiburg.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1055/a-1643-4209
?:doi
?:hasPublicationType
?:journal
  • Deutsche medizinische Wochenschrift (1946)
is ?:pmid of
?:pmid
?:pmid
  • 34826840
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • [Clinical benefit of Tocilizumab and other immunomodulating agents for treatment of COVID-19].
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34826840>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34826840>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all